ExodusPoint Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

ExodusPoint Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-33,132	Closed	-$377K	–	2181
2024 Q3	$377K	Buy	+33,132	New	+$333K	﹤0.01%	1289
2023 Q2	–	Sell	-17,944	Closed	-$337K	–	2326
2023 Q1	$337K	Buy	+17,944	New	+$295K	﹤0.01%	1445
2022 Q3	–	Sell	-176,472	Closed	-$2.69M	–	2387
2022 Q2	$2.69M	Buy	+176,472	New	+$2.61M	0.03%	650
2021 Q4	–	Sell	-221,509	Closed	-$4.78M	–	2695
2021 Q3	$4.78M	Buy	221,509 +129,424	+141%	+$3.12M	0.06%	416
2021 Q2	$2.36M	Buy	92,085 +10,954	+14%	+$234K	0.03%	605
2021 Q1	$1.48M	Buy	81,131 +59,517	+275%	+$989K	0.02%	704
2020 Q4	$249K	Buy	+21,614	New	+$198K	﹤0.01%	1627

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

ExodusPoint Capital Management's CDMO Position: Q4 2024 in Review

ExodusPoint Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 33,132 shares — an estimated $377K sold.

ExodusPoint Capital Management first reported a position in CDMO in Q4 2020 and held it in 7 quarters. The position peaked at $4.78M in Q3 2021. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

ExodusPoint Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
ExodusPoint Capital Management sold 33,132 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $377K.
ExodusPoint Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
ExodusPoint Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $4.78M in Q3 2021.
195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.